Thromboembolic events in COVID-19 ambulatory patients: An observational study about incidence, and thromboprophylaxis outcomes.

Rania HammamiJihen JdidiOlfa Chakroun-WalhaFadhila IssaouiNouha KtataHanen MaamriMouna BakloutiAmine BahloulRania GargouriAbdennour NasriSameh MsaadSamy KammounSamir KammounImen Ben RejabSelma CharfeddineLeila Abid

Published in: PloS one (2022)

Our study showed that the incidence of thromboembolic complications is very low in COVID-19 ambulatory patients. Paradoxically, there is an over prescription of thrombo-prophylaxis in this population.

Keyphrases

end stage renal disease
coronavirus disease
sars cov
newly diagnosed
chronic kidney disease
ejection fraction
risk factors
blood pressure
prognostic factors
peritoneal dialysis
type diabetes
insulin resistance